OPTIMIZING CO-MORBIDITY FOR THE PERIOPERATIVE PERIOD
9:00 am - 11:30 am, North Ballroom - 6th Floor
Course Code: SP-01
Speaker: ROBERT N. SLADEN, M.D.

Dr. Sladen - Receives funded research support from Eli Lilly Company and Scios Inc. as well as consultant fees/salary from Hospira, Inc. (Japan) and Orion Pharma.

Objective(s):
Objective(s): 1. Manage patients with co-morbidities such as diabetes, obesity, hypertension, and asthma in the perioperative period; 2. Devise anesthetic plans that take into consideration the issues related to patient’s co-morbidities such as diabetes, obesity, hypertension, and asthma.

1. Hypertension and Coronary Artery Disease

2. Diabetes

3. Obesity

4. Asthma/Bronchospasm

Cost: 0

Disclosures:
Dr. Konstadt - Does not have significant financial relationships with any commercial product, manufacturer or provider.
Dr. Nunnally - Does not have significant financial relationships with any commercial product, manufacturer or provider.
Dr. Brodsky - Does not have significant financial relationships with any commercial product, manufacturer or provider.